DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/scfl82/global) has announced the addition of the "Global Bioinsecticides Market - Growth, Trends, Forecast for the period (2015-2020)" report to their offering.
Worldwide, the pesticides industry has been witnessing a relatively steady growth, which has been primarily attributed to advancements in the Biopesticides industry. The value market for Bioinsecticides is forecast to exhibit a 2015-2020 CAGR of 16.6% in reaching a projected US$3.7 billion by 2020 from an estimated US$1.5 billion in 2014.
While the prevalence of chemical or synthetic pesticides in crop protection would continue, human, animal and environmental health concerns would play key roles in driving growth for Biopesticides. Though agricultural productivity has been largely dependent on synthetic insecticides, they come with their own set of shortcomings, such as being expensive, not being foolproof, tendency to accumulate in the environment and pollute waterways and being non-species specific, implying that their use can also harm non-target organisms.
Thus, the high specificity of Bioinsecticides towards pest, will drive the market. However, the need to use different Bioinsecticides for different pests apart from frequent reapplication instituted due to low life span will increase the cost sentiment among the growers, and in turn proving to be a constraint.
Growth in demand for bioinsecticides in Asia-Pacific is likely to be precipitated by the development of insecticide-resistant pests, requiring more efficacious solutions for either controlling or eliminating them. Bacillus thuringiensis is the entomopathogenic microorganism most extensively utilized as a bioinsecticide at global level. The value of bioinsecticides in the region is likely to post a 2014-2020 CAGR of 19.5%.
North American and European demands for bioinsecticides are forecast to register slower growths as the result of decreased insect pressure. However, compared to synthetic insecticides, demand for these products is likely to be stronger, particularly in Europe, after the EUs restriction on use of clothianidin, imidacloprid and thiametoxam from April 2013.
Key Topics Covered:
2. Key Findings of the Study
3. Market Overview
4. Market Dynamics
5. Market Segmentation
- Bioworks, Inc.
- Bayer Cropscience Ag
- Marrone BioInnovations
- Certis LLC
- Isagro Spa
- Novozyme biologicals
- Valent Biosciences Corporation
Koppert Biological systems
For more information visit http://www.researchandmarkets.com/research/scfl82/global